Page 15 - McGill University

Alzheimer's disease & dementia

Researchers identify correlation between MBI and Alzheimer's

In recent years, scientists have conducted more than 100 clinical trials in the hopes of finding new indicators capable of diagnosing Alzheimer's disease prior to the manifestation of clinical symptoms such as memory loss. ...

Medications

Promising advance in depression research

Depression is a common psychiatric disorder and one of the leading causes of disability worldwide. Antidepressants are the first-line treatment for moderate to severe major depressive episodes. Despite their effectiveness, ...

Diseases, Conditions, Syndromes

Designing face shields to protect medical staff

The COVID-19 pandemic has created an unprecedented need to provide personal protective equipment (PPE) for hospital staff. A team of Montreal medical experts has partnered with a 3-D printing company to design and distribute ...

Psychology & Psychiatry

The placebo effect and psychedelic drugs: tripping on nothing?

There has been a lot of recent interest in the use of psychedelic drugs to treat depression. A new study from McGill suggests that, in the right context, some people may experience psychedelic-like effects from placebos alone. ...

Diabetes

Getting off of the blood sugar roller coaster

For the 250,000 Canadians living with type 1 diabetes, the days of desperately trying to keep their blood sugar stable are coming to an end. A team of researchers at McGill University's Faculty of Medicine is working to optimize ...

Medical research

Researchers end decade-long search for mechanical pain sensor

Researchers at McGill University have discovered that a protein found in the membrane of our sensory neurons are involved in our capacity to feel mechanical pain, laying the foundation for the development of powerful new ...

page 15 from 40